Prime Medicine, Inc. - 10-Q Filing
Prime Medicine filed its 10-Q for the quarter ended March 31, 2026, providing financial and operational updates. The filing includes details on financial position, stockholder equity, and fair value of investments as of March 31, 2026, and March 31, 2025. It also outlines expenses related to general and administrative functions and research and development for the first quarter of 2026 compared to the same period in 2025.
Tickers: $PRME